B3GAT1, beta-1,3-glucuronyltransferase 1, 27087

N. diseases: 199; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease BEFREE Ten genes of importance for HNK-1 biosynthesis (B3GAT1, B3GAT2, and CHST10) or for the formation of perineuronal nets (TNR, BCAN, NCAN, HAPLN1, HAPLN2, HAPLN3, and HAPLN4) were investigated for potential involvement in schizophrenia (SCZ) susceptibility, by genotyping 104 tagSNPs in the Scandinavian Collaboration on Psychiatric Etiology sample (849 cases; 1602 control subjects). 20950796 2011
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease PSYGENET Ten genes of importance for HNK-1 biosynthesis (B3GAT1, B3GAT2, and CHST10) or for the formation of perineuronal nets (TNR, BCAN, NCAN, HAPLN1, HAPLN2, HAPLN3, and HAPLN4) were investigated for potential involvement in schizophrenia (SCZ) susceptibility, by genotyping 104 tagSNPs in the Scandinavian Collaboration on Psychiatric Etiology sample (849 cases; 1602 control subjects). 20950796 2011
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 Biomarker disease BEFREE Immunohistochemical localisation of the NK1 receptor in the human amygdala: preliminary investigation in schizophrenia. 16815618 2006
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 GeneticVariation disease BEFREE This leads us to the hypothesis that polymorphic or other variation of the 11q telomere may affect the activity of B3GAT1 and be a risk factor for schizophrenia and related psychoses in the general population. 12874601 2003
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.330 GeneticVariation disease LHGDN This leads us to the hypothesis that polymorphic or other variation of the 11q telomere may affect the activity of B3GAT1 and be a risk factor for schizophrenia and related psychoses in the general population. 12874601 2003
CUI: C2931456
Disease: Prostate cancer, familial
Prostate cancer, familial
0.300 Biomarker disease CTD_human Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016 2018
CUI: C4722327
Disease: PROSTATE CANCER, HEREDITARY, 1
PROSTATE CANCER, HEREDITARY, 1
0.300 Biomarker disease CTD_human Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016 2018
CUI: C0400966
Disease: Non-alcoholic Fatty Liver Disease
Non-alcoholic Fatty Liver Disease
0.300 Biomarker disease CTD_human CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. 24211274 2014
CUI: C3241937
Disease: Nonalcoholic Steatohepatitis
Nonalcoholic Steatohepatitis
0.300 Biomarker disease CTD_human CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. 24211274 2014
CUI: C0034069
Disease: Pulmonary Fibrosis
Pulmonary Fibrosis
0.200 Biomarker disease RGD Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis. 24127863 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.100 GeneticVariation disease GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE In addition to reviewing these cases, we reviewed the relevant literature pertaining to this form of cancer and assessed the immunohistochemical staining for CD57 on the available tumor samples. 31369187 2019
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 AlteredExpression group BEFREE To our knowledge, our findings provide new insights into the roles of KLRG1 and CD57 expression in human T cells, forming the basis for a refined model of CD8<sup>+</sup> T cell differentiation during CMV infection. 31554693 2019
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 Biomarker group BEFREE A population of Natural Killer (NK) cells expressing the activating receptor NKG2C and the maturation marker CD57 expands in response to human cytomegalovirus (HCMV) infection. 31211698 2019
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 AlteredExpression group BEFREE Whereas, FcRγ<sup>neg</sup> NK cells in CMV infection are reported to express increased levels of the maturation marker CD57, the FcRγ<sup>neg</sup> NK cells observed in our CMV-negative vaccine cohort express less CD57 than their FcRγ<sup>+</sup> counterparts. 31824507 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE Remarkably, upon 5 days in the developing neural tube, iHDAC-treated GBM cells ectopically expressed HNK-1, a tumor-suppressor marker tightly correlated to increased survivor of patients. 31531023 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE At baseline, NK cells in the tumor lymph node had a naïve phenotype albeit they were more differentiated than NK cells derived from control tonsils as determined by the frequency of CD56<sup>dim</sup> NK cells and the expression of killer cell immunoglobulin-like receptors (KIR), CD57 and CD16. 31572357 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.090 Biomarker group BEFREE The increase of CD8+CD57+ T cells in the peripheral blood of patients with cancer has been associated with prognosis, which suggests their suitability as a candidate immunological marker. 29928332 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE Neurokinin1 (NK1) receptor has played a vital role in the development of tumor. 29843798 2018
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 Biomarker group BEFREE We extend previous observations of the impact of CMV on CD8<sup>+</sup> T cell functionality to the CD4<sup>+</sup> T cell compartment, revealing CD57 as a polyfunctionality marker of T cells which expands after CMV infection. 27566833 2017
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 AlteredExpression group BEFREE With a mediation analysis we demonstrated that cytomegalovirus (CMV) infection, which is an important driving force of immunosenescence, largely accounted for elevated CD57 expression observed in ELA. 29089944 2017
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 AlteredExpression group BEFREE As chronic cytomegalovirus (CMV) infection is probably one of the major driving forces of immunosenescence, and its persistent infection results in functional and phenotypic changes to the T-cell repertoire, the aim of this study was to analyze the effect of CMV-seropositivity and aging on the expression of CD300a and CD161 inhibitory receptors, along with the expression of CD57 marker on CD4<sup>+</sup>, CD8<sup>+</sup>, CD8<sup>+</sup>CD56<sup>+</sup> (NKT-Like) and CD4<sup>-</sup>CD8<sup>-</sup> (DN) T-cell subsets. 28626460 2017
CUI: C0010823
Disease: Cytomegalovirus Infections
Cytomegalovirus Infections
0.090 Biomarker group BEFREE We here studied whether subclinical CD is associated with changes in blood CD57-expressing and Vδ1-expressing lymphocytes in children, and whether cytomegalovirus (CMV) infection modifies this association. 28456719 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 AlteredExpression group BEFREE Tumor stroma CD57 and CD8 expression was associated with lymphnode status and independently predicts survival of OSCC patients. 28549420 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.090 Biomarker group BEFREE Here, we report two rare cases of schwannoma-like tumor in the anterior cranial fossa that showed negative staining for Leu7, but positive staining for Schwann/2E, and discuss their origin. 27925298 2017